Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J. Kuter, Janet L. Nichol, Jeffrey S. Wasser et al.|The Lancet|2008Cited by 862
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)Stephen H. Petersdorf, Frederick R. Appelbaum, Cathryn Rankin et al.|American Journal of Hematology|2007Cited by 29
Early mortality (EM) for newly diagnosed multiple myeloma (NDMM) in the Connect MM U.S. registry.Howard R. Terebelo, Robert M. Rifkin, Jatin J. Shah et al.|Journal of Clinical Oncology|2013Cited by 3
Connect MM: The multiple myeloma (MM) disease registry—Incidence of second primary malignancies (SPM).Robert M. Rifkin, Brian G.M. Durie, Rafat Abonour et al.|Journal of Clinical Oncology|2012Cited by 2
Association of Race with Health-Related Quality of Life (HRQOL) Among Multiple Myeloma PatientsChris L. Pashos, Zeba Khan, Brian G.M. Durie et al.|Blood|2011Cited by 1